BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28716504)

  • 21. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
    Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
    Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five analytic challenges in working with electronic health records data to support clinical trials with some solutions.
    Goldstein BA
    Clin Trials; 2020 Aug; 17(4):370-376. PubMed ID: 32589046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing.
    Nicholls SG; Carroll K; Hey SP; Zwarenstein M; Zhang JZ; Nix HP; Brehaut JC; McKenzie JE; McDonald S; Weijer C; Fergusson DA; Taljaard M
    J Clin Epidemiol; 2021 Sep; 137():45-57. PubMed ID: 33789151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pros and cons of pragmatic clinical trials.
    Lurie JD; Morgan TS
    J Comp Eff Res; 2013 Jan; 2(1):53-8. PubMed ID: 24236521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the ethical and regulatory issues in pragmatic clinical trials.
    Califf RM; Sugarman J
    Clin Trials; 2015 Oct; 12(5):436-41. PubMed ID: 26374676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pragmatic (trial) informatics: a perspective from the NIH Health Care Systems Research Collaboratory.
    Richesson RL; Green BB; Laws R; Puro J; Kahn MG; Bauck A; Smerek M; Van Eaton EG; Zozus M; Hammond WE; Stephens KA; Simon GE
    J Am Med Inform Assoc; 2017 Sep; 24(5):996-1001. PubMed ID: 28340241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applying the pragmatic-explanatory continuum indicator summary to the implementation of a physical activity coaching trial in chronic obstructive pulmonary disease.
    Nguyen HQ; Moy ML; Fan VS; Gould MK; Xiang A; Bailey A; Desai S; Coleman KJ
    Nurs Outlook; 2018 Sep; 66(5):455-463. PubMed ID: 30144938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The GetReal Trial Tool: design, assess and discuss clinical drug trials in light of Real World Evidence generation.
    Zuidgeest MGP; Goetz I; Meinecke AK; Boateng D; Irving EA; van Thiel GJM; Welsing PMJ; Oude-Rengerink K; Grobbee DE;
    J Clin Epidemiol; 2022 Sep; 149():244-253. PubMed ID: 34929319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative.
    Dember LM; Archdeacon P; Krishnan M; Lacson E; Ling SM; Roy-Chaudhury P; Smith KA; Flessner MF
    J Am Soc Nephrol; 2016 Oct; 27(10):2955-2963. PubMed ID: 27401689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and implementation of PROgmatic: A clinical trial management system for pragmatic multi-centre trials, optimised for electronic data capture and patient-reported outcomes.
    Cramon P; Rasmussen ÅK; Bonnema SJ; Bjorner JB; Feldt-Rasmussen U; Groenvold M; Hegedüs L; Watt T
    Clin Trials; 2014 Jun; 11(3):344-354. PubMed ID: 24519964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mobile electronic versus paper case report forms in clinical trials: a randomized controlled trial.
    Fleischmann R; Decker AM; Kraft A; Mai K; Schmidt S
    BMC Med Res Methodol; 2017 Dec; 17(1):153. PubMed ID: 29191176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pragmatic trials and implementation science: grounds for divorce?
    Pawson R
    BMC Med Res Methodol; 2019 Aug; 19(1):176. PubMed ID: 31420024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using routine data to complement and enhance the results of randomised controlled trials.
    Lewsey JD; Leyland AH; Murray GD; Boddy FA
    Health Technol Assess; 2000; 4(22):1-55. PubMed ID: 11074392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pragmatic Applications of RE-AIM for Health Care Initiatives in Community and Clinical Settings.
    Glasgow RE; Estabrooks PE
    Prev Chronic Dis; 2018 Jan; 15():E02. PubMed ID: 29300695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of electronic systems to collect patient-reported outcome (PRO) data-recommendations for clinical trial teams: report of the ISPOR ePRO systems validation good research practices task force.
    Zbrozek A; Hebert J; Gogates G; Thorell R; Dell C; Molsen E; Craig G; Grice K; Kern S; Hines S
    Value Health; 2013 Jun; 16(4):480-9. PubMed ID: 23796281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "pragmatic trial": An essentially contested concept?
    Pawson R
    J Eval Clin Pract; 2019 Dec; 25(6):943-954. PubMed ID: 31313412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory.
    Johnson KE; Neta G; Dember LM; Coronado GD; Suls J; Chambers DA; Rundell S; Smith DH; Liu B; Taplin S; Stoney CM; Farrell MM; Glasgow RE
    Trials; 2016 Jan; 17():32. PubMed ID: 26772801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.